Stay updated on Injectable Cabotegravir vs TDF/FTC in MSM Clinical Trial

Sign up to get notified when there's something new on the Injectable Cabotegravir vs TDF/FTC in MSM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Injectable Cabotegravir vs TDF/FTC in MSM Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0. The study record area still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T03:56:12.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    A notice appears announcing NIH website updates and a transition in terminology from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-25T05:00:24.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2, while the study page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-18T04:44:56.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The footer site revision changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T05:26:30.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, blocking access to the study details and documents. The layout and navigation remain, but the main content is inaccessible due to the access restriction.
    Difference
    21%
    Check dated 2026-09-20T02:54:16.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    The website revision was updated from v3.6.5 to v3.6.6, indicating a small backend/frontend update that does not alter the study information or how users interact with the page.
    Difference
    0.0%
    Check dated 2026-08-30T00:58:53.000Z thumbnail image

Stay in the know with updates to Injectable Cabotegravir vs TDF/FTC in MSM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Injectable Cabotegravir vs TDF/FTC in MSM Clinical Trial page.